http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107669739-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72d18102281030861bd40c200fc79f71 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-54 |
| filingDate | 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_696fe9c18977ba78a5a2e58d90b4364c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215c092e77e7ebc480a0553c9ff3cdbf |
| publicationDate | 2018-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107669739-A |
| titleOfInvention | A kind of compound flavone oral liquid and preparation method thereof |
| abstract | The invention discloses a compound flavonoid oral liquid and a preparation method thereof. The oral liquid uses eagle tea-gingko flavonoid extract as a medicinal ingredient, and additionally contains auxiliary materials sodium benzoate, aspartame, acesulfame potassium and peach essence . The weights of each raw material contained in 1000ml oral liquid are: 50-80g of eagle tea flavonoid extract, 20-50g of ginkgo flavonoid extract, 0.5-1.5g of aspartame, 0.5-1.5g of acesulfame potassium, and peach flavor 0.2‑0.6g, the rest is water. The preparation method of the oral liquid is divided into multiple steps, and auxiliary materials are sequentially added in multiple steps, which can ensure the orderly and complete dissolution of each component and maintain the chemical stability of each component. Compared with the prior art, the effect of lowering blood sugar is obvious after taking the compound flavonoid oral liquid of the present invention for a period of time, and can control the blood sugar level and related risk factors of diabetic patients, thereby improving the quality of life of diabetic patients. |
| priorityDate | 2017-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 126.